Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia.

G Spignoli, G Pepeu

    European Journal of Pharmacology
    |July 31, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A plaster combining diclofenac and heparin: microcirculatory evaluation in 2 models of high-perfusion microangiopathy.

    Angiology·2005
    Same author

    Inhibition of acetylcholine-induced activation of extracellular regulated protein kinase prevents the encoding of an inhibitory avoidance response in the rat.

    Neuroscience·2005
    Same author

    Alzheimer Symposium. Etiopathogenetic mechanisms of Alzheimer's disease.

    IDrugs : the investigational drugs journal·2005
    Same author

    Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease.

    Neuroscience·2005
    Same author

    Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat.

    International journal of immunopathology and pharmacology·2004
    Same author

    Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.

    International journal of immunopathology and pharmacology·2003

    Electroconvulsive shock (ECS) significantly reduces acetylcholine levels and disrupts memory in rats. Oxiracetam, unlike piracetam, protects against ECS-induced memory deficits by preserving cholinergic function.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Cognitive Science

    Background:

    • Electroconvulsive shock (ECS) is known to disrupt memory and alter neurotransmitter levels.
    • Acetylcholine is a critical neurotransmitter involved in learning and memory processes.
    • Understanding the neurochemical basis of ECS-induced memory impairment is crucial for developing therapeutic interventions.

    Purpose of the Study:

    • To investigate the effects of ECS on acetylcholine levels in specific brain regions.
    • To evaluate the potential of oxiracetam and piracetam in preventing ECS-induced memory disruption.
    • To elucidate the role of cholinergic mechanisms in oxiracetam's protective effects.

    Main Methods:

    • Rats were subjected to ECS, and acetylcholine levels in the hippocampus and cerebral cortex were measured.

    Related Experiment Videos

  • A passive avoidance task was used to assess memory performance after ECS.
  • Oxiracetam and piracetam were administered prior to training to evaluate their effects on ECS-induced memory impairment and acetylcholine levels.

    • Main Results:

    • ECS caused a significant decrease in acetylcholine levels in the hippocampus and cerebral cortex.
    • ECS disrupted the acquisition of a passive avoidance response.
    • Oxiracetam dose-dependently prevented the ECS-induced decrease in acetylcholine and protected against memory disruption.
    • Piracetam was ineffective at the tested doses.
    • High-dose oxiracetam treatment resulted in significantly higher acetylcholine levels post-ECS compared to controls.

    Conclusions:

    • Oxiracetam demonstrates potential as a neuroprotective agent against ECS-induced memory deficits.
    • The findings suggest that oxiracetam's efficacy is mediated through the modulation of hippocampal and cortical cholinergic systems.
    • Oxiracetam's ability to preserve acetylcholine levels is a key factor in its memory-enhancing and protective effects.